|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
ABSTRACT |
|---|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Increased airway smooth muscle (ASM) within the bronchial wall of asthmatic patients has been well documented and is likely to be the result of increased muscle proliferation. We have for the first time been able to culture ASM cells from asthmatic patients and to compare their proliferation rate with that of nonasthmatic patients. Asthmatic ASM cell cultures (n = 12) were established from explanted lungs and endobronchial biopsies. Nonasthmatic ASM cells (n = 10) were obtained from explanted tissue from patients with no airway disease, emphysema, carcinoma, and fibrosing alveolitis. Cell counts, tritiated thymidine incorporation, and cell cycle analysis were conducted over 7 d. Asthmatic ASM cell numbers at Days 3, 5, and 7 were significantly higher than corresponding values for nonasthmatic cells (p < 0.05). Tritiated thymidine incorporation was increased 3.2-fold in asthmatic cells compared with nonasthmatic cells within the first 24 h (p = 0.026). Flow cytometric analysis of DNA content on Days 1 and 2 revealed that a significantly greater percentage of asthmatic ASM cells were in the G2 + M phase (p < 0.05). This study shows for the first time that proliferation of ASM cells is increased in patients with asthma and provides evidence for an intrinsic abnormality in the ASM cell in this disease.
Keywords: asthma; human airway smooth muscle; cell culture; cell proliferation; hyperplasia
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Airway remodeling is a key feature of asthma. Part of this remodeling is characterized by an increase in the amount of airway smooth muscle (ASM) within the airway wall (1). This is likely to be an important etiologic factor in airway narrowing that accompanies asthma (4). Although there has been some uncertainty as to whether this is caused by hyperplasia or hypertrophy, studies indicate that both abnormalities occur, with a preponderance of hyperplasia (3). The cause of this hyperplasia is unknown, although many inflammatory mediators produce mitogenesis in a variety of animal and human ASM cells. However, these studies have been unable to address the differences between asthmatic and nonasthmatic cells because ASM cells from asthmatic patients were not available. Recently we and others have reported that exposure of nonasthmatic cells to serum from atopic asthmatic patients results in differences in cell cycling and cytokine production (5, 6). In addition, Naureckas and coworkers have found that cells from nonasthmatic individuals showed increased cell proliferation in the presence of bronchoalveolar lavage fluid (BALF) from asthmatic patients, an effect which was further accentuated when the BALF was obtained after allergen challenge (7). Thus the preceding studies have addressed the issue of whether asthmatic serum and lavage fluid are able to induce enhanced proliferation of nonasthmatic ASM cells.
In this study we have been able to culture ASM cells from asthmatic patients and thereby address the pivotal question as to whether asthmatic cells exhibit a different pattern of proliferation from that of cells obtained from nonasthmatic patients.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Human ASM cells were obtained from 10 nonasthmatics and 12 asthmatics by methods adapted from those previously described (8). Approval for all experiments with human lung was provided by the human ethics committee of the University of Sydney and the Central Sydney Area Health Service. Nonasthmatic human ASM was obtained from bronchial airways of 10 patients undergoing resection for either
lung transplantation or carcinoma. Asthmatic ASM was obtained from
two patients undergoing resection for lung transplantation, one patient
dying in status asthmaticus, and nine deep endobronchial biopsies obtained by flexible bronchoscopy (see Table 1 for patient details). Pure
ASM bundles were dissected free from surrounding tissue with the aid
of a dissecting microscope. The small pieces of muscle bundles were
then plated in 12-cm2 flasks as previously described (8). ASM cell
characteristics were determined by immunofluorescence and light microscopy. Cells were stained with antibodies against 
-smooth muscle
actin and calponin while omission of the primary antibody was used as
a control (11). Sensitization status was assessed, as previously described (5) in two bronchial rings obtained from each of the lung specimens (excluding the endobronchial biopsy specimens).
|
Experimental Design
The ASM cells (passage 4 to 8) from the 22 patients were seeded at a density of 1 × 104 cells/cm2 for all experiments. Cells were plated in 5% fetal bovine serum (FBS) in Dulbecco's modified Eagle medium (DMEM) for 24 h and the medium was changed to 1% FBS in DMEM for a further 24 h to synchronize the cells. After 24 h in 1% FBS in DMEM, the cells were counted (designated Day 0); the medium was then changed to 5% FBS in DMEM.
Tritiated Thymidine Assay
ASM cells were seeded in triplicate in 24-well plates. After 24 h in 1% FBS in DMEM the medium was changed to either 1% or 5% FBS containing 1 µCi/well tritiated thymidine. After 24-h exposure, tritiated thymidine incorporation was assessed. Cells were washed with Dulbecco's phosphate-buffered saline (PBS), fixed with methanol: acetic acid (3:1), washed again with Dulbecco's PBS, then lysis performed with 0.5 M NaOH. The cell lysate (200 µl) was then added to 2 ml scintillant, the solution mixed, and counts per minute (cpm) were determined on a Beckman scintillation counter. Results were expressed as a percentage of the cpm in the presence of 1% FBS.
Flow Cytometric Analysis of DNA Content
ASM cells were seeded in duplicate in 6-well plates. After 24 h in 1% FBS in DMEM the medium was changed to 5% FBS. The ASM cells from the different patients were harvested from the wells using phenol red-free trypsin-ethylenediaminetetraacetic acid (EDTA) at 24 and 48 h. Cells were then immediately permeabilized and stained in the unfixed state using a solution of 0.5% wt/vol saponin and 0.1% wt/vol bovine serum albumin (BSA) in PBS containing propidium iodide, 50 µg/ ml, and ribonuclease A, 50 µg/ml. Data from the stained cell suspensions were acquired on a FACSCalibur Sort (Becton Dickinson, Sydney, Australia) using Cell Quest software (Becton Dickinson). The resulting DNA profiles were analyzed using FL2 peak area and width and Modfit software (Verity Software House Inc., Topsham, ME) to determine the percentage of cells in each phase of the cell cycle.
Cell Counting
ASM cells were seeded in triplicate in 12-well plates. After 24 h in 1% FBS in DMEM the medium was changed to 5% FBS and manual cell counting performed on Days 0, 3, 5, and 7. Results are expressed as a percentage of the cell counts on Day 0. Cell viability was determined by trypan blue exclusion as previously described (8).
Materials
The following compounds were obtained from the sources given in parentheses: DMEM, Dulbecco's PBS, penicillin, streptomycin, amphotericin B, trypan blue (Life Technologies, Melbourne, Australia); EDTA disodium salt, (Ajax, Sydney, Australia); FBS (CSL, Sydney, Australia); saponin, BSA, propidium iodide, ribonuclease A, fluorescein isothiocyanate (FITC)-conjugated monoclonal anti- smooth muscle actin (mouse IgG2 isotype), monoclonal anti-calponin (mouse
IgG1), FITC-conjugated goat anti-mouse IgG, acetylcholine perchlorate, and chemicals to make Krebs-Henseleit solution (Sigma, Sydney, Australia); emulsifier safe (scintillant) (Canberra-Packard, Melbourne, Australia); antigen extracts of Dermatophagoides pteronyssinus standardized mite DP 30,000 BAU/ml, Timothy Phleum Pratense 1:20 wt/vol, Alternaria tenuis 1:10 wt/vol, and cat pelt 10,000 bioequivalent allergy units (BAU)/ml (Miles Laboratories, Inc., Elkhart, IN).
Statistics
Results from duplicate or triplicate wells from each individual patient were averaged and an overall mean and SE were calculated from values obtained from the 12 asthmatic and 10 nonasthmatic patients. Analysis of variance (ANOVA) using repeated measures and the Fisher projected least significant difference (PLSD) post test was performed on the results for tritiated thymidine, cell counts on individual days, and flow cytometric analysis of DNA content. Factorial ANOVA was performed on the proliferation curves comparing the asthmatic and nonasthmatic cells. In all cases a p value of less than 0.05 was considered significant.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Under light microscopy, both the asthmatic and nonasthmatic
cells appeared spindle-shaped, with central oval nuclei containing prominent nucleoli, and displayed the typical "hill and
valley" proliferation pattern in culture. Cells from both asthmatic and nonasthmatic patients showed uniform staining for
both the smooth muscle-specific contractile proteins -smooth
muscle actin (Figure 1A) and calponin (Figure 1B), indicating
that these cells were ASM. Cells from asthmatic patients proliferated significantly faster than cells from control subjects as
assessed by manual cell counting, tritiated thymidine incorporation, and fluorescent-activated cell sorter (FACS) analysis
of DNA content. Cell numbers at Days 3, 5, and 7 were 238 ± 23, 301 ± 34, and 381 ± 38%, respectively of values for Day 0 in the asthmatic group. Corresponding values in control cells
were significantly lower at each time point
193 ± 24, 210 ± 21, and 229 ± 24%, respectively (p < 0.05) (Figure 2). Statistical analysis of the proliferation curves comparing the asthmatic cells with control cells revealed a significant difference
between the curves (ANOVA factorial analysis) with the asthmatic proliferation curve lying to the left (Figure 2). The doubling time for the asthmatic cells was significantly increased compared with control, 2.9 ± 0.4 and 5.4 ± 1.3 d, respectively (p < 0.05). Cell viability as determined by trypan blue exclusion was greater than 99%. Tritiated thymidine incorporation
was increased 3.2-fold in asthmatic cells compared with controls within the first 24 h (89 ± 13% nonasthmatic and 281 ± 54% asthmatic p < 0.05) (Figure 3). Flow cytometric analysis
of DNA content revealed that a significantly greater percentage of asthmatic cells were in the G2 + M phase than controls
at 24 and 48 h (7 ± 2% nonasthmatic and 15 ± 1% asthmatic
for 24 h [Figures 4A and 4B] and 9 ± 2% nonasthmatic and 14 ± 2% asthmatic for 48 h).
|
|
|
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The cause of the increase in bulk of the ASM in the airways of asthmatic patients has been the focus of extensive research. Although many groups have identified mediators that have the potential to increase the proliferation of cultured ASM cells, no groups have reported on the proliferation of asthmatic ASM cells in culture. This study is the first to report that ASM cells obtained from asthmatic patients proliferate faster in culture than those obtained from nonasthmatic patients. In addition, this is the first report of the growth of human ASM cells from muscle bundles obtained from endobronchial biopsies.
Under light microscopy, cells from both groups looked similar. Cells from both groups showed uniform staining for the
smooth-muscle specific contractile proteins -smooth muscle
actin and the smooth muscle-specific protein, calponin (12).
The only other cell with the same morphology which may have
contaminated our cultures is the fibroblast; however, calponin
is undetectable in fibroblasts (12) and thus the presence of this
cell type in our cultures is unlikely. Moreover, Stewart has observed that when the proliferation of asthmatic fibroblasts obtained from endobronchial biopsies is compared with that of
nonasthmatic control subjects, there is a relative decrease in
the proliferation of the asthmatic fibroblasts, thus further
highlighting the differences between fibroblasts and ASM
cells (personal communication, Alastair Stewart 2000). There
is a remote possibility that myofibroblasts may have contributed to the cell population; however, whether myofibroblasts
can be distinguished from myocytes is controversial. Moreover, the site from which we obtain our muscle cells (i.e., the
smooth muscle bundles) makes it unlikely that myofibroblasts
were included, because these cells have been reported to be
located immediately beneath the basement membrane and
not within the ASM bundles.
Care must be taken when extrapolating from results of cells in culture to in vivo conditions; however, the fact that our results indicate that an inherent abnormality of the ASM proliferation exists suggests that this may be representative of the in vivo situation. Our results showed a substantial increase in the proliferation of the asthmatic cells in culture, which may translate to a small increase in vivo; however, the period over which the increase in the ASM in the airways of asthmatic patients occurs may be extended, suggesting that any alteration in the proliferation of the muscle over time may have profound effects on muscle bulk. Given that our results would indicate the presence of an intrinsic abnormality in the proliferation characteristics of the ASM from asthmatic patients, the nature of this abnormality would have to be such that it is maintained in culture conditions and through several passages. There are precedents for this phenomenon. Das and coworkers reported that fibroblasts obtained from chronic hypoxia-induced pulmonary hypertensive neonatal calves exhibited increased proliferation which was maintained in culture and indeed through several passages (13).
The exact nature of the abnormality producing the accelerated muscle proliferation in the cells from asthmatic patients remains to be elucidated. Recent evidence points to an active participation of the ASM in inflammatory responses, in that these cells can produce cytokines, express adhesion molecules for inflammatory cells and a variety of cell surface molecules including Fas (14), and can produce a number of extracellular matrix proteins (15), matrix metalloproteinases and their inhibitors (16). Many of the cytokines produced by the ASM can induce proliferation; thus, the ASM may respond in an autocrine manner to overproduction of one or more of these cytokines (5). Moreover, animal studies indicate that inflammatory mediators have the potential to induce hyperplasia of the ASM in vivo (17).
The cells used in this study were obtained from both resection specimens and from endobronchial biopsies. The question arose as to whether the source of the cells would influence proliferation patterns. The ASM cells obtained from biopsies exhibited a similar proliferation pattern to cells obtained from asthmatic resection specimens. Because the asthmatic patient group was younger than the nonasthmatic group, this could have influenced the proliferation pattern. However, a recent study of fibroblasts isolated from 150 patients indicates that donor age does not influence proliferation pattern of cells in culture (18). Moreover, when we analyzed a subset of our patients with a similar mean age of 45 ± 1 yr (mean ± SD, n = 3) for asthmatics and 51 ± 2 yr (mean ± SD, n = 3) for nonasthmatics, although the number for comparison was small we still observed significant changes in cell proliferation. Moreover, when we looked at the preoperative diagnosis of a subset of patients (all chronic obstructive pulmonary disease [COPD], n = 5), it was observed that proliferation was significantly less and the doubling time was significantly greater in the COPD group compared with the asthmatics (asthmatics 2.9 ± 04 and COPD 6.6 ± 2.1 d), highlighting the differences in pathophysiology of COPD and asthma.
Previous studies have used models of asthmatic airways to examine the proliferation of human ASM. Black and Johnson examined the effect of passive sensitization of nonasthmatic ASM and observed that antigen exposure increased the proliferation of the smooth muscle (5). Others have shown that bronchoalveolar lavage (BAL) from asthmatic patients contains substances that are mitogenic for ASM and that this mitogenesis is enhanced after allergen challenge (7). Whereas these studies point to the influence of allergic or asthmatic factors influencing the proliferation of the ASM, the present study shows for the first time that, regardless of its environment, the asthmatic ASM is intrinsically able to grow more rapidly. This abnormality may explain the consistent finding of increased ASM in asthmatic airways in vivo.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to P.R.A. Johnson, Ph.D., Department of Pharmacology, University of Sydney, NSW Australia 2006. E-mail: pjohno{at}pharmacol.usyd.edu.au
(Received in original form October 23, 2000 and in revised form March 16, 2001).
Acknowledgments: The authors acknowledge the collaborative effort of the cardiopulmonary transplant team and pathologists at St. Vincent's Hospital. They thank Dr. J. Rimmer for her assistance in this project.
Supported by the National Health and Medical Research Council, Australia, the Australian Lung Foundation, University of Sydney Medical Foundation, and the Rebecca L. Cooper Medical Research Foundation.
| |
References |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Dunnill MS,
Massarella GR,
Anderson JA.
A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and emphysema.
Thorax
1969;
24:
176-179
2. Carroll N, Elliot J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993; 147: 405-410 [Medline].
3. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscle underlying bronchial asthma. Am Rev Respir Dis 1993; 148: 720-726 [Medline].
4.
Lambert RK,
Wiggs BR,
Kuwano K,
Hogg JC,
Pare PD.
Functional significance of increased airway smooth muscle in asthma and COPD.
J
Appl Physiol
1993;
74:
2771-2781
5.
Black JL,
Johnson PR.
What determines asthma phenotype? Is it the interaction between allergy and the smooth muscle?
Am J Respir Crit
Care Med
2000;
161:
S207-210
6. Hakonarson H, Maskeri N, Carter C, Grunstein M. Regulation of TH1 and TH2 type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J Clin Invest 1999; 103: 1077-1087 [Medline].
7.
Naureckas ET,
Ndukwu IM,
Halayko AJ,
Maxwell C,
Hershenson MB,
Solway J.
Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle.
Am J Respir Crit Care Med
1999;
160:
2062-2066
8.
Johnson PR,
Armour CL,
Carey D,
Black JL.
Heparin and PGE2 inhibit
DNA synthesis in human airway smooth muscle cells in culture.
Am J
Physiol
1995;
269:
L514-519
9.
Hawker K,
Johnson P,
Hughes J,
Black J.
Interleukin-4 inhibits mitogen-induced proliferation of human airway smooth muscle cells in culture.
Am J Physiol
1998;
275:
L469-477
10.
Carlin S,
Yang KX,
Donnelly R,
Black JL.
Protein kinase C isoforms in
human airway smooth muscle cells: activation of PKC-
during proliferation.
Am J Physiol
1999;
276:
L506-512
11. Durand-Arczynska W, Marmy N, Durand J. Caldesmon, calponin and alpha-smooth muscle actin expression in subcultured smooth muscle cells from human airways. Histochem 1993; 100: 465-471 .
12.
Halayko AJ,
Salari H,
Ma X,
Stephens NL.
Markers of airway smooth
muscle cell phenotype.
Am J Physiol
1996;
270:
L1040-1051
13.
Das M,
Dempsey E,
Bouchey D,
Reyland ME,
Stenmark KR.
Chronic
hypoxia induces exaggerated growth responses in pulmonary artery
adventitial fibroblasts: potential contribution of specific protein kinase C isozymes.
Am J Respir Cell Mol Biol
2000;
22:
15-25
14.
Hamann KJ,
Vieira JE,
Halayko AJ,
Dorscheid D,
White SR,
Forsythe SM,
Camoretti-Mercado B,
Rabe KF,
Solway J.
Fas cross-linking induces apoptosis in human airway smooth muscle cells.
Am J Physiol
2000;
278:
L618-624
15. Johnson P, Underwood P, Carlin S, Armour C, Black J. Human atopic asthmatic serum causes increased production of matrix proteins from human airway smooth muscle cells in culture. Am J Respir Crit Care Med 1998; 157: A268 .
16. Johnson P, Black J, Perruchoud A, Tamm M, Roth M. Atopic asthmatic serum alters expression of matrix metalloproteinases in human bronchial smooth muscle cells. Am J Respir Crit Care Med 1999; 159: A260 .
17. Touvay C, Pfister A, Vilain B, Carre C, Page CP, Lellouch-Tubiana A, Pignol B, Mencia-Huerta JM, Braquet P. Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig. Pulm Pharmacol 1991; 4: 43-51 [Medline].
18.
Cristofalo VJ,
Allen RG,
Pignolo RJ,
Martin BG,
Beck JC.
Relationship
between donor age and the replicative lifespan of human cells in culture: a reevaluation.
Proc Natl Acad Sci USA
1998;
95:
10614-10619
This article has been cited by other articles:
 |
|
 |
|
  J. K. Burgess, S. Boustany, L. M. Moir, M. Weckmann, J. Y. Lau, K. Grafton, M. Baraket, P. M. Hansbro, N. G. Hansbro, P. S. Foster, et al. Reduction of Tumstatin in Asthmatic Airways Contributes to Angiogenesis, Inflammation, and Hyperresponsiveness Am. J. Respir. Crit. Care Med., January 15, 2010; 181(2): 106 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. J. Dekkers, H. Maarsingh, H. Meurs, and R. Gosens Airway Structural Components Drive Airway Smooth Muscle Remodeling in Asthma Proceedings of the ATS, December 15, 2009; 6(8): 683 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Black, B. G. G. Oliver, and M. Roth Molecular Mechanisms of Combination Therapy With Inhaled Corticosteroids and Long-Acting {beta}-Agonists Chest, October 1, 2009; 136(4): 1095 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Kramer, E. M. Mushaben, P. A. Pastura, T. H. Acciani, G. H. Deutsch, G. K. Khurana Hershey, T. R. Korfhagen, W. D. Hardie, J. A. Whitsett, and T. D. Le Cras Early Growth Response-1 Suppresses Epidermal Growth Factor Receptor-Mediated Airway Hyperresponsiveness and Lung Remodeling in Mice Am. J. Respir. Cell Mol. Biol., October 1, 2009; 41(4): 415 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Labonte, M. Hassan, P.-A. Risse, K. Tsuchiya, M. Laviolette, A.-M. Lauzon, and J. G. Martin The effects of repeated allergen challenge on airway smooth muscle structural and molecular remodeling in a rat model of allergic asthma Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L698 - L705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. John, Y. M. Zhu, C. E. Brightling, L. Pang, and A. J. Knox Human Airway Smooth Muscle Cells from Asthmatic Individuals Have CXCL8 Hypersecretion Due to Increased NF-{kappa}B p65, C/EBP{beta}, and RNA Polymerase II Binding to the CXCL8 Promoter J. Immunol., October 1, 2009; 183(7): 4682 - 4692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Klagas, S. Goulet, G. Karakiulakis, J. Zhong, M. Baraket, J. L. Black, E. Papakonstantinou, and M. Roth Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD Eur. Respir. J., September 1, 2009; 34(3): 616 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Malavia, C. B. Raub, S. B. Mahon, M. Brenner, R. A. Panettieri Jr., and S. C. George Airway Epithelium Stimulates Smooth Muscle Proliferation Am. J. Respir. Cell Mol. Biol., September 1, 2009; 41(3): 297 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Seidel, I. Merfort, J. M. Hughes, B. G. G. Oliver, M. Tamm, and M. Roth Dimethylfumarate inhibits NF-{kappa}B function at multiple levels to limit airway smooth muscle cell cytokine secretion Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L326 - L339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mahn, S. J. Hirst, S. Ying, M. R. Holt, P. Lavender, O. O. Ojo, L. Siew, D. E. Simcock, C. G. McVicker, V. Kanabar, et al. Diminished sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma PNAS, June 30, 2009; 106(26): 10775 - 10780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fukuyama, T. Nakano, T. Matsumoto, B. G. G. Oliver, J. K. Burgess, A. Moriwaki, K. Tanaka, M. Kubo, T. Hoshino, H. Tanaka, et al. Pulmonary Suppressor of Cytokine Signaling-1 Induced by IL-13 Regulates Allergic Asthma Phenotype Am. J. Respir. Crit. Care Med., June 1, 2009; 179(11): 992 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Fanta Asthma N. Engl. J. Med., March 5, 2009; 360(10): 1002 - 1014. [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Michoud, R. Robert, M. Hassan, B. Moynihan, C. Haston, V. Govindaraju, P. Ferraro, J. W. Hanrahan, and J. G. Martin Role of the Cystic Fibrosis Transmembrane Conductance Channel in Human Airway Smooth Muscle Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 217 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Simcock, V. Kanabar, G. W. Clarke, K. Mahn, C. Karner, B. J. O'Connor, T. H. Lee, and S. J. Hirst Induction of Angiogenesis by Airway Smooth Muscle From Patients with Asthma Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 460 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Summer and A. Fine Mesenchymal Progenitor Cell Research: Limitations and Recommendations Proceedings of the ATS, August 15, 2008; 5(6): 707 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zuyderduyn, M. B. Sukkar, A. Fust, S. Dhaliwal, and J. K. Burgess Treating asthma means treating airway smooth muscle cells Eur. Respir. J., August 1, 2008; 32(2): 265 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Meurs, R. Gosens, and J. Zaagsma Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models Eur. Respir. J., August 1, 2008; 32(2): 487 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Ward, T. Harris, T. Bamford, A. Mast, M. C. F. Pain, C. Robertson, D. Smallwood, T. Tran, J. Wilson, and A. G. Stewart Proliferation is not increased in airway myofibroblasts isolated from asthmatics Eur. Respir. J., August 1, 2008; 32(2): 362 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Siddiqui, F. Hollins, and C. E. Brightling What can we learn about airway smooth muscle from the company it keeps? Eur. Respir. J., July 1, 2008; 32(1): 9 - 11. [Full Text] [PDF]
|
|
|
|
|
|
N. Regamey, M. Ochs, T. N. Hilliard, C. Muhlfeld, N. Cornish, L. Fleming, S. Saglani, E. W. F. W. Alton, A. Bush, P. K. Jeffery, et al. Increased Airway Smooth Muscle Mass in Children with Asthma, Cystic Fibrosis, and Non-Cystic Fibrosis Bronchiectasis Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 837 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Q. Yang, J. J. Rudiger, J. M. Hughes, S. Goulet, M. M. Gencay-Cornelson, P. Borger, M. Tamm, and M. Roth Cell Density and Serum Exposure Modify the Function of the Glucocorticoid Receptor C/EBP Complex Am. J. Respir. Cell Mol. Biol., April 1, 2008; 38(4): 414 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Panettieri Jr., M. I. Kotlikoff, W. T. Gerthoffer, M. B. Hershenson, P. G. Woodruff, I. P. Hall, and S. Banks-Schlegel Airway Smooth Muscle in Bronchial Tone, Inflammation, and Remodeling: Basic Knowledge to Clinical Relevance Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 248 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Murphy, R. Summer, and A. Fine Stem Cells in Airway Smooth Muscle: State of the Art Proceedings of the ATS, January 1, 2008; 5(1): 11 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Martin and T. Jo Genetic Differences in Airway Smooth Muscle Function Proceedings of the ATS, January 1, 2008; 5(1): 73 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Bentley and M. B. Hershenson Airway Smooth Muscle Growth in Asthma: Proliferation, Hypertrophy, and Migration Proceedings of the ATS, January 1, 2008; 5(1): 89 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Trian, G. Benard, H. Begueret, R. Rossignol, P.-O. Girodet, D. Ghosh, O. Ousova, J.-M. Vernejoux, R. Marthan, J.-M. Tunon-de-Lara, et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma J. Exp. Med., December 24, 2007; 204(13): 3173 - 3181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Shepherd, S. M. Duffy, T. Harris, G. Cruse, M. Schuliga, C. E. Brightling, C. B. Neylon, P. Bradding, and A. G. Stewart KCa3.1 Ca2+Activated K+ Channels Regulate Human Airway Smooth Muscle Proliferation Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 525 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Gawaziuk, X. Ma, F. Sheikh, Z-Q. Cheng, P. A. Cattini, and N. L. Stephens Transforming growth factor-{beta} as a differentiating factor for cultured smooth muscle cells Eur. Respir. J., October 1, 2007; 30(4): 643 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lu, S. Xie, M. B. Sukkar, X. Lu, M. F. Scully, and K. F. Chung Inhibition of Airway Smooth Muscle Adhesion and Migration by the Disintegrin Domain of ADAM-15 Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 494 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Matsumoto, L. M Moir, B. G G Oliver, J. K Burgess, M. Roth, J. L Black, and B. E McParland Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma Thorax, October 1, 2007; 62(10): 848 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. James and S. Wenzel Clinical relevance of airway remodelling in airway diseases Eur. Respir. J., July 1, 2007; 30(1): 134 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. McVicker, S.-Y. Leung, V. Kanabar, L. M. Moir, K. Mahn, K. F. Chung, and S. J. Hirst Repeated Allergen Inhalation Induces Cytoskeletal Remodeling in Smooth Muscle from Rat Bronchioles Am. J. Respir. Cell Mol. Biol., June 1, 2007; 36(6): 721 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bradding Mast cell regulation of airway smooth muscle function in asthma Eur. Respir. J., May 1, 2007; 29(5): 827 - 830. [Full Text] [PDF]
|
|
|
|
|
|
E. D. Fixman, A. Stewart, and J. G. Martin Basic mechanisms of development of airway structural changes in asthma Eur. Respir. J., February 1, 2007; 29(2): 379 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Ammit, L. M. Moir, B. G. Oliver, J. M. Hughes, H. Alkhouri, Q. Ge, J. K. Burgess, J. L. Black, and M. Roth Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L199 - L206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Takeda, M. Kondo, S. Ito, Y. Ito, K. Shimokata, and H. Kume Role of RhoA Inactivation in Reduced Cell Proliferation of Human Airway Smooth Muscle by Simvastatin Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 722 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kaur, R. Saunders, P. Berger, S. Siddiqui, L. Woodman, A. Wardlaw, P. Bradding, and C. E. Brightling Airway Smooth Muscle and Mast Cell-derived CC Chemokine Ligand 19 Mediate Airway Smooth Muscle Migration in Asthma Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1179 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Govindaraju, M.-C. Michoud, M. Al-Chalabi, P. Ferraro, W. S. Powell, and J. G. Martin Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration Am J Physiol Cell Physiol, November 1, 2006; 291(5): C957 - C965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gosens, G. L. Stelmack, G. Dueck, K. D. McNeill, A. Yamasaki, W. T. Gerthoffer, H. Unruh, A. S. Gounni, J. Zaagsma, and A. J Halayko Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L523 - L534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Wenzel and S. Balzar Myofibroblast or smooth muscle: do in vitro systems adequately replicate tissue smooth muscle? Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 364 - 365. [Full Text] [PDF]
|
|
|
|
|
|
P. Borger, M. Tamm, J. L. Black, and M. Roth Asthma: Is It Due to an Abnormal Airway Smooth Muscle Cell? Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 367 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Chan, J. K. Burgess, J. C. Ratoff, B. J. O'Connor, A. Greenough, T. H. Lee, and S. J. Hirst Extracellular Matrix Regulates Enhanced Eotaxin Expression in Asthmatic Airway Smooth Muscle Cells Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 379 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. An, B. Fabry, X. Trepat, N. Wang, and J. J. Fredberg Do Biophysical Properties of the Airway Smooth Muscle in Culture Predict Airway Hyperresponsiveness? Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 55 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Canonica Treating Asthma as an Inflammatory Disease Chest, July 1, 2006; 130(1_suppl): 21S - 28S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bergeron and L.-P. Boulet Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest, April 1, 2006; 129(4): 1068 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Boxall, S. T. Holgate, and D. E. Davies The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma Eur. Respir. J., January 1, 2006; 27(1): 208 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. A. Johnson, J. K. Burgess, Q. Ge, M. Poniris, S. Boustany, S. M. Twigg, and J. L. Black Connective Tissue Growth Factor Induces Extracellular Matrix in Asthmatic Airway Smooth Muscle Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 32 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Burgess, Q. Ge, M. H. Poniris, S. Boustany, S. M. Twigg, J. L. Black, and P. R. A. Johnson Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L153 - L161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Chung The Role of Airway Smooth Muscle in the Pathogenesis of Airway Wall Remodeling in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 347 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Black, Q. Ge, S. Boustany, P. R. A. Johnson, M. H. Poniris, A. R. Glanville, B. G. G. Oliver, L. M. Moir, and J. K. Burgess In vitro studies of lymphangioleiomyomatosis Eur. Respir. J., October 1, 2005; 26(4): 569 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Chung Evaluation of Selective Prostaglandin E2 (PGE2) Receptor Agonists as Therapeutic Agents for the Treatment of Asthma Sci. Signal., September 27, 2005; 2005(303): pe47 - pe47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Brightling, A. J. Ammit, D. Kaur, J. L. Black, A. J. Wardlaw, J. M. Hughes, and P. Bradding The CXCL10/CXCR3 Axis Mediates Human Lung Mast Cell Migration to Asthmatic Airway Smooth Muscle Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1103 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Citro, S. Ravasi, G. E. Rovati, and V. Capra Thromboxane Prostanoid Receptor Signals Through Gi Protein to Rapidly Activate Extracellular Signal-Regulated Kinase in Human Airways Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 326 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T.-B. Nguyen, J. P. T. Ward, and S. J. Hirst {beta}1-Integrins Mediate Enhancement of Airway Smooth Muscle Proliferation by Collagen and Fibronectin Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Jeffery Remodeling and Inflammation of Bronchi in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 176 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Lalor, B. Truong, S. Henness, A. E. Blake, Q. Ge, A. J. Ammit, C. L. Armour, and J. M. Hughes Mechanisms of serum potentiation of GM-CSF production by human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1007 - L1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.G. Stewart Emigration and immigration of mesenchymal cells: a multicultural airway wall Eur. Respir. J., October 1, 2004; 24(4): 515 - 517. [Full Text] [PDF]
|
|
|
|
|
|
S. A. Shore Airway Smooth Muscle in Asthma -- Not Just More of the Same N. Engl. J. Med., August 5, 2004; 351(6): 531 - 532. [Full Text] [PDF]
|
|
|
|
|
|
M. Roth, P. R.A. Johnson, P. Borger, M. P. Bihl, J. J. Rudiger, G. G. King, Q. Ge, K. Hostettler, J. K. Burgess, J. L. Black, et al. Dysfunctional Interaction of C/EBP{alpha} and the Glucocorticoid Receptor in Asthmatic Bronchial Smooth-Muscle Cells N. Engl. J. Med., August 5, 2004; 351(6): 560 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Black Asthma--More Muscle Cells or More Muscular Cells? Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 980 - 981. [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Cho, M. Miller, K. J. Baek, J. W. Han, J. Nayar, M. Rodriguez, S. Y. Lee, K. McElwain, S. McElwain, E. Raz, et al. Immunostimulatory DNA Inhibits Transforming Growth Factor-{beta} Expression and Airway Remodeling Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 651 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Woodruff, G. M. Dolganov, R. E. Ferrando, S. Donnelly, S. R. Hays, O. D. Solberg, R. Carter, H. H. Wong, P. S. Cadbury, and J. V. Fahy Hyperplasia of Smooth Muscle in Mild to Moderate Asthma without Changes in Cell Size or Gene Expression Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 1001 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Grootendorst and K. F. Rabe Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shinagawa and M. Kojima Mouse Model of Airway Remodeling: Strain Differences Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 959 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.T. Holgate, D. E. Davies, S. Puddicombe, A. Richter, P. Lackie, J. Lordan, and P. Howarth Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma Eur. Respir. J., September 20, 2003; 22(44_suppl): 24s - 29s. [Full Text] [PDF]
|
|
|
|
|
|
P. Jeffery, S. Holgate, and S. Wenzel Methods for the Assessment of Endobronchial Biopsies in Clinical Research: Application to Studies of Pathogenesis and the Effects of Treatment Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): S1 - 17. [Full Text] [PDF]
|
|
|
|
|
|
L. S. Chambers, J. L. Black, Q. Ge, S. M. Carlin, W. W. Au, M. Poniris, J. Thompson, P. R. Johnson, and J. K. Burgess PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L619 - L627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Taille, A. Almolki, M. Benhamed, C. Zedda, J. Megret, P. Berger, G. Leseche, E. Fadel, T. Yamaguchi, R. Marthan, et al. Heme Oxygenase Inhibits Human Airway Smooth Muscle Proliferation via a Bilirubin-dependent Modulation of ERK1/2 Phosphorylation J. Biol. Chem., July 11, 2003; 278(29): 27160 - 27168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Madison Migration of Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., July 1, 2003; 29(1): 8 - 11. [Full Text] [PDF]
|
|
|
|
|
|
S T Holgate, D E Davies, G Murphy, R M Powell, and J W Holloway ADAM 33: just another asthma gene or a breakthrough in understanding the origins of bronchial hyperresponsiveness? Thorax, June 1, 2003; 58(6): 466 - 469. [Full Text] [PDF]
|
|
|
|
|
|
L. Benayoun, A. Druilhe, M.-C. Dombret, M. Aubier, and M. Pretolani Airway Structural Alterations Selectively Associated with Severe Asthma Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1360 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Burgess, P. R. A. Johnson, Q. Ge, W. W. Au, M. H. Poniris, B. E. McParland, G. King, M. Roth, and J. L. Black Expression of Connective Tissue Growth Factor in Asthmatic Airway Smooth Muscle Cells Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Parameswaran, G. Cox, K. Radford, L. J. Janssen, R. Sehmi, and P. M. O'Byrne Cysteinyl Leukotrienes Promote Human Airway Smooth Muscle Migration Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 738 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Black The Role of Mast Cells in the Pathophysiology of Asthma N. Engl. J. Med., May 30, 2002; 346(22): 1742 - 1743. [Full Text] [PDF]
|
|
|
|
|
|
M. J. TOBIN Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618. [Full Text] [PDF]
|
|
|
|
|
|
S. Page, A. J. Ammit, J. L. Black, and C. L. Armour Human mast cell and airway smooth muscle cell interactions: implications for asthma Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1313 - L1323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. BLACK, M. ROTH, J. LEE, S. CARLIN, and P. R. A. JOHNSON Mechanisms of Airway Remodeling . Airway Smooth Muscle Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S63 - 66. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |